{"transactions":[{"id":700051,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2026-07-31T20:06:15.000Z","date":"2026-07-29","kind":"purchase","planned":false,"acquired":true,"shares":7736,"price":2.585,"value":19997.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement under a Securities Purchase Agreement dated July 29, 2026 (\"SPA\"), which purchase is exempt from the registration requirements of Section 5 of the Securities Exchange Act of 1934, as amended, pursuant to Section 4(a)(2) thereof and/or Rule 506(b) of Regulation D thereunder. Additionally, the reporting person is entitled to receive common warrants exercisable for an aggregate of up to 7,736 shares of common stock. Under the terms of the SPA, issuance of the common warrants is subject to stockholder approval under Nasdaq Listing Rule 5635(d). Upon issuance, the common warrants will be exercisable immediately and expire 5.5 years from date of issuance."}],"balance_after":8691,"source":{"system":"sec-edgar","filing":"0001493152-26-035631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000149315226035631/ownership.xml","form_type":"4"}},{"id":1153877,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock Purchase Warrant","published_at":"2025-05-09T21:29:21.000Z","date":"2025-05-07","kind":"purchase","planned":false,"acquired":true,"shares":481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025,  along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company."}],"balance_after":481,"derivative":{"exercise_price":26,"exercise_date":"2025-05-07","expiration_date":"2030-05-07","underlying":"Common Stock","underlying_shares":481},"source":{"system":"sec-edgar","filing":"0000950170-25-068275","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000095017025068275/ownership.xml","form_type":"4"}},{"id":1153876,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2025-05-09T21:29:21.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":962,"price":26,"value":25012.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025,  along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company."}],"balance_after":5720,"source":{"system":"sec-edgar","filing":"0000950170-25-068275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000095017025068275/ownership.xml","form_type":"4"}},{"id":1625668,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2024-02-22T19:20:25.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":71429,"price":1.4,"value":100000.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":190238,"source":{"system":"sec-edgar","filing":"0001209191-24-003783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919124003783/doc4.xml","form_type":"4"}},{"id":1716476,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-11T21:56:11.000Z","date":"2023-12-08","kind":"exercise","planned":false,"acquired":false,"shares":7501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant vested on September 16, 2022; and 35% of the total shares subject to the stock option grant vested on September 16, 2023."}],"balance_after":0,"derivative":{"exercise_price":0.14,"expiration_date":"2029-09-18","underlying":"Common Stock","underlying_shares":7501},"source":{"system":"sec-edgar","filing":"0001209191-23-058081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919123058081/doc4.xml","form_type":"4"}},{"id":1716475,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2023-12-11T21:56:11.000Z","date":"2023-12-08","kind":"exercise","planned":false,"acquired":true,"shares":7501,"price":0.14,"value":1050.14,"ownership":{"direct":true},"balance_after":118809,"source":{"system":"sec-edgar","filing":"0001209191-23-058081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919123058081/doc4.xml","form_type":"4"}},{"id":1860878,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-10T00:00:30.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":false,"shares":5356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023."}],"balance_after":7501,"derivative":{"exercise_price":0.14,"expiration_date":"2029-09-18","underlying":"Common Stock","underlying_shares":5356},"source":{"system":"sec-edgar","filing":"0001209191-23-036087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919123036087/doc4.xml","form_type":"4"}},{"id":1860877,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2023-06-10T00:00:30.000Z","date":"2023-06-08","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.1574,"value":21574.0,"ownership":{"direct":true},"balance_after":111308,"source":{"system":"sec-edgar","filing":"0001209191-23-036087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919123036087/doc4.xml","form_type":"4"}},{"id":1860876,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2023-06-10T00:00:30.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":true,"shares":5356,"price":0.14,"value":749.84,"ownership":{"direct":true},"balance_after":101308,"source":{"system":"sec-edgar","filing":"0001209191-23-036087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919123036087/doc4.xml","form_type":"4"}},{"id":2486433,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-03T17:10:42.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":4285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023."}],"balance_after":12857,"derivative":{"exercise_price":0.14,"expiration_date":"2029-12-18","underlying":"Common Stock","underlying_shares":4285},"source":{"system":"sec-edgar","filing":"0001209191-21-067740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919121067740/doc4.xml","form_type":"4"}},{"id":2486432,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2021-12-03T17:10:42.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":4285,"price":0.14,"value":599.9,"ownership":{"direct":true},"balance_after":95952,"source":{"system":"sec-edgar","filing":"0001209191-21-067740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919121067740/doc4.xml","form_type":"4"}},{"id":2573421,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-10T21:46:50.000Z","date":"2021-09-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025."}],"balance_after":50000,"derivative":{"exercise_price":4.31,"expiration_date":"2031-09-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-055528","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919121055528/doc4.xml","form_type":"4"}},{"id":2592539,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2021-08-24T21:05:36.000Z","date":"2021-08-23","kind":"purchase","acquired":true,"shares":5605,"price":3.953,"value":22156.565,"ownership":{"direct":true},"balance_after":91667,"source":{"system":"sec-edgar","filing":"0001209191-21-053170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919121053170/doc4.xml","form_type":"4"}},{"id":2592538,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2021-08-24T21:05:36.000Z","date":"2021-08-20","kind":"purchase","acquired":true,"shares":7853,"price":4.0837,"value":32069.2961,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $4.06 to $4.166. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":86062,"source":{"system":"sec-edgar","filing":"0001209191-21-053170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919121053170/doc4.xml","form_type":"4"}},{"id":2592537,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2021-08-24T21:01:23.000Z","date":"2021-08-19","kind":"purchase","acquired":true,"shares":10532,"price":4.2934,"value":45218.0888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $4.293 to $4.31 The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":78209,"source":{"system":"sec-edgar","filing":"0001209191-21-053163","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919121053163/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-23"}},{"id":2593712,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2021-08-23T23:53:22.000Z","date":"2021-08-19","kind":"purchase","acquired":true,"shares":10532,"price":4.2523,"value":44785.2236,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $4.2519 to $4.27. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":78209,"source":{"system":"sec-edgar","filing":"0001209191-21-053050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919121053050/doc4.xml","form_type":"4"}},{"id":2626126,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27520,"kind":"person","name":"Flowers Lee","position":1,"cik":"0001866254","reported_name":"Flowers Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Business Development"}}],"security":"Common Stock","published_at":"2021-07-23T23:29:36.000Z","date":"2021-07-22","kind":"purchase","acquired":true,"shares":31250,"price":8,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock purchased jointly by Lee and Wendy Flowers."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock purchased in connection with the Issuer's initial public offering for consideration of $8.00 per share."}],"balance_after":67677,"source":{"system":"sec-edgar","filing":"0001209191-21-048080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866254/000120919121048080/doc4.xml","form_type":"4"}}]}